Invesco
NUVB icon

Invesco’s Nuvation Bio NUVB Stock Holding History

Invesco’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.34M Buy
587,392
+149,586
+34% +$731K ﹤0.01% 2376
2026
Q1 		$1.88M Sell
437,806
-747,337
-63% -$4.16M ﹤0.01% 2574
2025
Q4 		$10.6M Buy
1,185,143
+687,597
+138% +$4.26M ﹤0.01% 1807
2025
Q3 		$1.84M Buy
497,546
+104,132
+26% +$284K ﹤0.01% 2647
2025
Q2 		$767K Buy
393,414
+25,642
+7% +$53.4K ﹤0.01% 2964
2025
Q1 		$647K Buy
367,772
+37,384
+11% +$85.1K ﹤0.01% 3047
2024
Q4 		$879K Buy
330,388
+7,344
+2% +$18.9K ﹤0.01% 2968
2024
Q3 		$740K Sell
323,044
-2,164
-0.7% -$6.6K ﹤0.01% 3049
2024
Q2 		$950K Buy
325,208
+3,194
+1% +$9.75K ﹤0.01% 2957
2024
Q1 		$1.17M Buy
322,014
+88,892
+38% +$171K ﹤0.01% 2917
2023
Q4 		$352K Buy
233,122
+11,337
+5% +$14.6K ﹤0.01% 3380
2023
Q3 		$297K Buy
221,785
+3,980
+2% +$6.62K ﹤0.01% 3463
2023
Q2 		$392K Sell
217,805
-1,612
-0.7% -$2.74K ﹤0.01% 3376
2023
Q1 		$364K Buy
219,417
+170,142
+345% +$345K ﹤0.01% 3432
2022
Q4 		$94.6K Buy
49,275
+130
+0.3% +$263 ﹤0.01% 3836
2022
Q3 		$110K Sell
49,145
-132
-0.3% -$377 ﹤0.01% 3820
2022
Q2 		$159K Sell
49,277
-12,422
-20% -$54.2K ﹤0.01% 3791
2022
Q1 		$325K Sell
61,699
-946
-2% -$5.32K ﹤0.01% 3599
2021
Q4 		$533K Buy
62,645
+29,225
+87% +$269K ﹤0.01% 3364
2021
Q3 		$332K Buy
33,420
+13,072
+64% +$118K ﹤0.01% 3613
2021
Q2 		$189K Buy
+20,348
New +$232K ﹤0.01% 3801

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Invesco's NUVB Position: Q2 2026 in Review

Invesco increased its Nuvation Bio (NUVB) stake by 34% in Q2 2026, buying an estimated $731K and bringing the position to 587,392 shares worth $3.34M. The position accounts for ﹤0.01% of the portfolio, ranked #2376.

Invesco first reported a position in NUVB in Q2 2021 and has held it in 21 quarters since. The position peaked at $10.6M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Invesco held 587,392 shares of Nuvation Bio worth $3.34M as of Q2 2026.
  • Invesco bought 149,586 Nuvation Bio shares in Q2 2026, an estimated $731K.
  • Nuvation Bio made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2376 holding.
  • Invesco first reported a position in Nuvation Bio in Q2 2021 and has held it in 21 quarters since.
  • Invesco's Nuvation Bio position peaked at $10.6M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.